Medical research

Ivermectin does not prevent progression to severe COVID-19

Ivermectin treatment during early illness does not prevent progression to severe disease for high-risk patients with mild-to-moderate COVID-19, according to a study published online Feb. 18 in JAMA Internal Medicine.

Diseases, Conditions, Syndromes

COVID-19 hospitalization costs, outcomes in 2020 improved over time

A new study published in Advances in Therapy provides the first comprehensive analysis of the hospitalization costs for COVID-19 patients, factors associated with costs and length of stay, and the monthly trends of costs ...

Diseases, Conditions, Syndromes

COVID-19 Omicron wave in South Africa characterized

(HealthDay)—In South Africa, the pattern of patients hospitalized with COVID-19 early in the fourth wave showed fewer hospitalizations and reduced severity of illness compared with earlier waves, according to a research ...

HIV & AIDS

Impact of HIV virus on COVID-19 disease

A new study found that during the early months of the COVID-19 pandemic people living with HIV were less likely to die from COVID than persons without HIV. Hospitalized patients with HIV and COVID were less likely to require ...

Diseases, Conditions, Syndromes

Clinically active IBD linked to adverse COVID-19 outcomes

(HealthDay)—Clinically active inflammatory bowel disease (IBD) is associated with adverse COVID-19 outcomes, especially in younger and middle-aged adults, according to a study published online Sept. 27 in the Journal of ...

page 4 from 14